What is Uncovr?
Uncovr operates at the intersection of artificial intelligence and clinical operations, providing software solutions that streamline documentation, workflow optimization, and data management. By leveraging machine learning to analyze complex clinical information generated during surgical and patient care procedures, the platform transforms unstructured data into actionable, compliant medical records. This technological approach addresses a critical pain point in modern healthcare: the high administrative overhead that often detracts from direct patient care. By automating the documentation process, Uncovr enables clinicians to maintain higher standards of recordkeeping accuracy while simultaneously improving operational efficiency within hospital systems and private practices.
How much funding has Uncovr raised?
Uncovr has raised a total of $7M across 1 funding round:
Seed
$7M
Seed (2026): $7M with participation from Index Ventures, Frst, No Label Ventures, Entrepreneur First, and Seedcamp
Key Investors in Uncovr
Index Ventures
Index Ventures is a global venture firm investing in the next generation of entrepreneurs from seed to IPO, partnering with founders who challenge the status quo.
Frst
Frst Capital is a seed-stage venture firm founded in 2019 that is specifically focused on supporting and scaling French entrepreneurial talent.
No Label Ventures
No Label Ventures is a specialized firm dedicated to supporting immigrant entrepreneurs in Europe, providing early-stage capital and strategic networking opportunities.
What's next for Uncovr?
With this recent infusion of capital, Uncovr is poised to transition from its initial development phase into a period of aggressive market expansion and product maturation. The company's strategic roadmap likely involves deepening its integration with existing electronic health record systems and expanding its footprint across European and international healthcare markets. As the demand for AI-driven healthtech solutions continues to rise, Uncovr is expected to focus on enhancing its data processing capabilities to support more complex clinical environments. The backing from prominent venture firms suggests a strong institutional confidence in the company's ability to disrupt traditional medical documentation practices and establish a new standard for clinical data management.
See full Uncovr company page
